Apr 2023 $39 M No. 7 $10 to $50 million 21
Hera Therapeutics Inc.: Raise no. 7, Apr 2023 × Investors in this round 21 investors had bought by the notice of Oct 11, 2024: 21 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $39 M of $53 M offered; $14 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Elaine Chien · Executive Officer Kristine Ball · Executive Officer, Director Raju Gadiraju · Executive Officer Sarah Walter · Executive Officer Beni Rovinski · Director Brian Goodman · Director Clifford Samuel · Director Florencia Segal · Director Gail Maderis · Director Wende Hutton · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Kristine Ball, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Oct 11, 2024. Read the notice at the SEC .
equity, options SEC Oct 2021 $16 M No. 6 $10 to $50 million 20
Hera Therapeutics Inc.: Raise no. 6, Oct 2021 × Investors in this round 20 investors had bought by the notice of Nov 3, 2021: 20 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $16 M of $31 M offered; $15 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Gail Maderis · Executive Officer, Director Oranee Daniels · Executive Officer Raju Gadiraju · Executive Officer Sarah Walter · Executive Officer Benjamin Rovinski · Director Clifford Samuel · Director David Kabakoff · Director Jenny Yip · Director Steven James · Director Vinzenz Ploerer · Director Wende Hutton · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Gail Maderis, Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 3, 2021. Read the notice at the SEC .
equity SEC Jul 2018 $15 M No. 5 $10 to $50 million 8
Hera Therapeutics Inc.: Raise no. 5, Jul 2018 × Investors in this round 8 investors had bought by the notice of Jul 19, 2018: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $15 M of $15 M offered
Smallest investment taken no minimum stated
What was sold equity, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Gail Maderis · Executive Officer, Director Oranee D. Daniels · Executive Officer Raju D. Gadiraju, Ph.D. · Executive Officer Sarah P. Walter · Executive Officer Benjamin P. Rovinski · Director David P. Kabakoff, Ph.D. · Director Michael D. Cannon · Director Steven P. James · Director Ting P. Jia · Director Vinzenz P. Ploerer · Director Wende S. Hutton · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Alan C. Mendelson, Secretary. Source: SEC Form D, newest notice filed Jul 19, 2018. Read the notice at the SEC .
equity SEC Feb 2017 $15 M No. 4 $10 to $50 million 15
Hera Therapeutics Inc.: Raise no. 4, Feb 2017 × Investors in this round 15 investors had bought by the notice of Aug 28, 2017: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $15 M of $26 M offered; $11 M still to sell
Smallest investment taken no minimum stated
What was sold equity, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Gail Maderis · Executive Officer, Director Oranee D. Daniels · Executive Officer Raju P. Gadiraju, Ph.D. · Executive Officer Sarah P. Walter · Executive Officer Benjamin P. Rovinski · Director David P. Kabakoff · Director Michael D. Cannon · Director Steven P. James · Director Vinzenz P. Ploerer · Director Wendee S. Hutton · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Alan C. Mendelson, Secretary. Source: SEC Form D and 1 amendment, newest notice filed Aug 28, 2017. Read the notice at the SEC .
equity SEC May 2015 $9 M No. 3 $2 to $10 million 26
Hera Therapeutics Inc.: Raise no. 3, May 2015 × Investors in this round 26 investors had bought by the notice of Jun 11, 2015: 26 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $9 M of $16 M offered; $7 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $18,288 (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John Sayward · Executive Officer David Kabakoff · Director Michael Cannon · Director Steven James · Director Wende Hutton · Director William Respess · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John Sayward, Acting Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 11, 2015. Read the notice at the SEC .
equity SEC Dec 2014 $2 M No. 2 Under $2 million 19
Hera Therapeutics Inc.: Raise no. 2, Dec 2014 × Investors in this round 19 investors had bought by the notice of Dec 23, 2014: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $3 M offered; $1 M still to sell
Smallest investment taken $1
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John W. Sayward · Executive Officer · Chief Operating Officer, Chief Financial Officer and Treasurer Karl Y. Hostetler · Executive Officer, Director · President and Chief Executive Officer Michael J. Sullivan · Executive Officer · Secretary Michael D. Cannon · Director William L. Respess · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “This filing covers the purchase and sale of Series B Preferred Stock, which includes the conversion of convertible promissory notes.”Signed by John W. Sayward, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 23, 2014. Read the notice at the SEC .
equity SEC Feb 2013 $1 M No. 1 Under $2 million 18
Hera Therapeutics Inc.: Raise no. 1, Feb 2013 × Investors in this round 18 investors had bought by the notice of Sep 5, 2013: 18 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken $25,000
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Karl Y Hostetler · Executive Officer, Director Michael J Sullivan · Executive Officer Michael D. Cannon · Director William Y Respess · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Michael J. Sullivan, Corporate Secretary. Source: SEC Form D, newest notice filed Sep 5, 2013. Read the notice at the SEC .
equity SEC